Remove 2030 Remove Drug Development Remove Health IT Remove Pharmaceuticals
article thumbnail

Fujifilm Announces Asset Purchase Agreement with Inspirata, Inc. to Acquire the Company’s Digital Pathology Business

Healthcare IT Today

Future releases of Dynamyx will also create opportunities for Fujifilm to support pharmaceutical and contract research organizations with toxicity testing data management for drug development. “A For more information about Fujifilm’s Sustainable Value Plan 2030, click here.